Loading...
Options B.R.O.
Example search prompt
Example search prompt
Example search prompt
Example search prompt
Divis Laboratories share price came under pressure in stock market today, slipping sharply after the company announced its December quarter results. The reaction was quick. Investors responded within minutes of opening trade.Here’s what really happened — and what the numbers tell us.Market Perfor...
Divi's Labs Q3 Results are out. And the numbers tell a mixed but steady story.For the quarter ended December 31, 2025 (Q3FY26), Divi’s Laboratories reported a marginal dip in net profit. At the same time, income continued to grow at a healthy pace.The market reaction stayed positive. Investors fo...
The Q3 results 2026 season has entered a decisive phase. Over 290 companies are scheduled to announce their December quarter earnings today, February 11.This isn’t just another earnings day. It’s one of the busiest sessions of the quarter. Big names like Mahindra & Mahindra (M&M), Ashok L...
India’s Contract Development and Manufacturing Organisation (CDMO) sector is once again gaining strong investor attention, supported by global supply-chain diversification, competitive cost structures, and favourable policy momentum. As the US moves ahead with the Biosecure Act, companies with hi...
Market PerformanceDivis Laboratories' share price fell to ₹6,545 in early trade on Monday.This marks a 3.5% decline from the previous close, with the stock trading at ₹6,603 around 9:30 AM.Despite the decline, the stock has gained over 20% in the last three months.Main News: Patent Loss Poses Thr...
Market Performance: Sensex and Nifty End Higher on July 8On Tuesday, July 8, benchmark Indian indices — the Sensex and Nifty 50 — ended the trading session in positive territory, buoyed by gains in heavyweight financial stocks.Sensex climbed 270 points or 0.32% to finish at 83,712.51Nifty 50 adva...
Market PerformanceOn July 8, Indian pharmaceutical stocks experienced a notable dip in early trade as global trade tensions escalated. The Nifty Pharma index slipped nearly 1%, hovering around 22,159 during morning hours.This marked the second straight day of losses for the index, after an extend...
The Indian stock market bounced back on Friday, July 4, with benchmark indices — Sensex and Nifty 50 — closing modestly higher after a rangebound session. The gains were supported by heavyweight stocks, despite ongoing trade concerns and cautious investor sentiment.Market PerformanceSensex ended ...
India's benchmark indices—the Sensex and the Nifty 50—closed lower on Thursday, July 3, amid ongoing concerns around global cues, foreign fund outflows, and uncertainty in the India-US trade talks. Here's a detailed look at the day's market performance and highlights.Market PerformanceThe Sensex ...
Market Performance: Sensex and Nifty Dip Amid Choppy SessionOn July 2, Indian stock markets closed in the red after a volatile trading session. The pressure was primarily seen in the real estate and financial sectors.Sensex dropped 287.60 points or 0.34%, ending at 83,409.69Nifty slipped 88.40 po...
Market PerformanceOn Tuesday, July 1, the Indian stock market remained essentially flat amid cautious sentiment triggered by global uncertainties and domestic trade concerns.Sensex gained 91 points or 0.11% to close at 83,697.29Nifty 50 rose by 25 points or 0.10%, ending at 25,541.80Despite the m...
Market PerformanceDespite a weak broader market on June 12, Nifty Pharma outshone as the only sectoral gainer, climbing nearly 1% to 22,243 in morning trade.This uptrend in pharma shares was primarily driven by easing global trade concerns after U.S. President Donald Trump's announcement regardin...
Market PerformanceOn Monday, May 19, Indian stock markets declined for the second consecutive day, led by negative global cues and heightened volatility.Sensex closed at 82,059.42, down 271 points or 0.33%Nifty 50 ended at 24,944.45, down 75 points or 0.30%While benchmark indices slipped, BSE Mid...
Market PerformanceThe Nifty Pharma Index witnessed a sharp correction in Monday's early trade, sliding over 2% amid renewed concerns over US drug pricing.The index opened at 20,949.70It dropped to an intraday low of 20,576.05This marked a decline of more than 2% from the previous close of 21,071....
Open Free Trading & Demat Account
Trusted by 5.5 Lakh+ Investors
By proceeding, you agree to our Privacy Policy and Terms and Conditions.
Easy & quick
1. Register on SCORES portal
2. Mandatory details for filling complaints on SCORES
Name | PAN | Address | Mobile | Number | E-mail ID
3. Benefits
Effective Communication
Speedy redressal of the grievances
